History
| 1969 | Established with capital of JPY 5 million; started manufacture of first aid bandages |
|---|---|
| 1972 | Established the Hydrogel Patch Department |
| 1979 | Completed the GMP certified Himata Plant (Plant No. 1) |
| 1985 | Completed the General Research Center |
| 1988 | Completed the Himata Plant (Plant No. 2) Acquired marketing authorization for the transdermal absorption patch Adofeed® (the present Adofeed® Pap 40mg for prescription use) |
| 1994 | Completed the Hisagane Plant in Kamiichi Started export to Italy and South Africa (TransAct® LAT) |
| 1995 | Started exporting flurbiprofen to Europe |
| 1998 | Started export to Brazil (Targus® LAT) |
| 2000 | Started exporting menthol products to the United States |
| 2006 | Acquired manufacturing and marketing authorization for Loxonin® Pap 100mg (for prescription use) Expanded the Hisagane Plant |
| 2008 | Acquired marketing authorization for Loxonin® Tape 50mg and 100mg (for prescription use) Acquired marketing authorization for Adofeed® Pap 80mg |
| 2011 | Completed the Hisagane Plant (East Plant) |
| 2015 | Started export of Loxonin® Tape 50mg to China Acquired marketing authorization for Loxonin®S Pap, Loxonin®S Tape and Loxonin®S Tape L (behind-the-counter products) |
| 2016 | Ibuprofen Medicated Plaster approved for registration in 6 European countries |
| 2017 | Submitted application for registration of Loxonin® Pap in countries of the ASEAN region |
| 2018 | Started export of Ibuprofen Medicated Plaster for commercialization in Belgium, Ireland and UK Ibuprofen Medicated Plaster approved for registration in 16 additional European countries |
| 2019 | Ibuprofen Medicated Plaster was granted the “Product of the Year” award in UK, being the only OTC medicine to win the award in that year |
| 2021 | Completed the Research Center |
| 2023 | Completed the Hisagane Plant South (Packaging & Warehousing) |